Corticosteroid in tuberculous meningitis.

Abstract

We assessed the benefit of prednisolone regimen in adult-patients with tuberculous meningitis by a randomised, double-blind trial. 59 patients were treated with combined antituberculous drugs and randomised to receive oral prednisolone regimen or a placebo. There were 29 and 30 patients in the treatment and placebo groups respectively. The results revealed that prednisolone was not beneficial in patients with severe brain lesions, increased intracranial pressure and cranial nerve palsies. The role of prednisolone in patients with paraparesis, visual impairment and newly developed neurological complications during treatment needs further study.

• Authors: V Chotmongkol, S Jitpimolmard, Y Thavornpitak
• Journal: Journal of the Medical Association of Thailand = Chotmaihet thangphaet (J Med Assoc Thai) Vol. 79 Issue 2 Pg. 83-90 (Feb 1996) ISSN: 0125-2208 [Print] Thailand
• PMID: 8868018 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)

Chemical References

• Anti-Inflammatory Agents
• Antitubercular Agents
• Prednisolone

Topics

• Adolescent
• Adult
• Aged
• Aged, 80 and over
• Anti-Inflammatory Agents (administration & dosage, therapeutic use)
• Antitubercular Agents (therapeutic use)
• Cerebrospinal Fluid (drug effects)
• Chi-Square Distribution
• Double-Blind Method
• Female
• Humans
• Male
• Middle Aged
• Prednisolone (administration & dosage, therapeutic use)
• Prospective Studies
• Treatment Outcome
• Tuberculosis, Meningeal (diagnosis, drug therapy, physiopathology)